Catherine Koofhethile

Advancing the HIV Cure Agenda: Catherine Koofhethile at the PAHCS Launch

Catherine Koofhethile’s participation in the launch of the Pan-African HIV Clinicians Society (PAHCS) signals a decisive step toward placing HIV cure science at the centre of Africa’s clinical and policy agenda. With growing global momentum around achieving durable remission, and ultimately a cure, Koofhethile represents a critical voice ensuring that Africa is not only included in this frontier, but actively shaping it.

Her work aligns closely with the emerging shift from lifelong HIV management to cure-oriented strategies. These include immune-based therapies, early treatment interventions, and research into viral reservoirs, areas that require both scientific advancement and robust implementation frameworks. Koofhethile’s strength lies in bridging these domains, ensuring that cure research is grounded in real-world systems capable of delivering complex interventions at scale.

Drawing from Botswana’s globally recognised HIV programme, she brings deep experience in integrating innovation into national health systems. Botswana’s success in expanding universal treatment access and adopting new therapeutic approaches demonstrates how strong systems can accelerate scientific progress. Koofhethile has been part of this ecosystem, supporting programme design, inclusive policies, and data-driven strategies that ensure equitable access to care.

Her presence at PAHCS reinforces the organisation’s commitment to linking cutting-edge research with clinical delivery. As PAHCS seeks to unify African clinicians and drive leadership in HIV care, Koofhethile introduces a vital implementation perspective, one that ensures scientific breakthroughs translate into measurable patient outcomes across diverse healthcare settings.

At the launch, her contribution is expected to shape conversations around how Africa can prepare for the rollout of future cure strategies. This includes strengthening infrastructure, aligning policy frameworks, and fostering collaboration across countries to support multicentre trials and eventual scale-up.

Catherine Koofhethile represents the often under-recognised but essential layer of the HIV response: the systems that make innovation possible. Her involvement at PAHCS signals that the society is not only looking toward the future of HIV science, but is actively preparing the continent to deliver it.